Safety and Efficacy of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter, Open-Label, Phase II StudyYuqin Song, Jun Zhu, Wei Xu et al.|Blood|2019Cited by 27
Long-Term Safety and Efficacy of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter, Open-Label, Phase II StudyYuqin Song, Jun Zhu, Yongping Song et al.|Blood|2020Cited by 17
Pooled Analysis of Safety Data from Clinical Trials of Orelabrutinib Monotherapy in Hematologic MalignanciesYuqin Song, Jun Zhu, Wei Xu et al.|Blood|2020Cited by 16